Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events

  • Technology appraisal guidance
  • TA210
  • Published: 
Download guidance (PDF)

Update information

February 2014: Implementation section updated to clarify that clopidogrel and modified-release dipyridamole is recommended as an option for preventing occlusive vascular events.

ISBN: 978-1-4731-6655-4